Clinical Trial Update: A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase I clinical trial evaluating ROSE12 alone and in combination with other anti-tumor agents in patients with solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ROSE12

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Solid Tumor | Phase 1 | Status: RECRUITING